PALI compared with CNTX: revenue, margins and what each company keeps, and the suppliers and customers both name

PALIPalisade Bio, Inc.

Mkt capRevenueRevenue

CNTXContext Therapeutics Inc.

Mkt capRevenueRevenue

Compare

PALIPalisade Bio, Inc.

CNTXContext Therapeutics Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

PALIPalisade Bio, Inc.

1.17· pre 1.16· delayed

Mkt cap$202.2MRevenue$500,000Q2 FY26

CNTXContext Therapeutics Inc.

0.20· pre 0.19

Pre-marketSep 2 '83

Mkt cap$17.4MRevenue—

Compare

Pre-marketSep 2 '83

PALIPalisade Bio, Inc.

CNTXContext Therapeutics Inc.

1.17pre 1.16delayed

Price

0.20pre 0.19

$202.2M

Mkt cap

$17.4M

Q2 FY26$500,000

Revenue

—

PALI1.17vsCNTX0.20Pre-marketSep 2 '83

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

PALI: latest quarter is a loss; flow not drawable. CNTX: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PALI 2

—Giiant Pharmaunlistedsupplier

—Newsoaraunlistedcustomer

Shared 0

No shared counterparties.

Only CNTX 6

—BioAtla, Inc. ("BioAtla")unlistedsupplier

—Integral Molecular, Inc. ("Integral")unlistedsupplier

—Just-Evotec Biologicsunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—Link (assignment for the benefit of creditors), LLC ("Link")unlistedsupplier

2 more · CNTX chain ›

Price

rebased to 0%

PALI, solidCNTX, dashed